Brief: Ryvu Therapeutics Q3 Net Loss Narrows To 11.8 Mln Zlotys
Nov 23 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q3 NET LOSS OF 11.8 MILLION ZLOTYS VERSUS LOSS OF 22.8
MILLION
ZLOTYS YEAR AGO
* Q3 OPERATING REVENUE 19.7 MILLION ZLOTYS VERSUS 7.0
MILLION
ZLOTYS YEAR AGO
* Q3 OPERATING LOSS OF 12.9 MILLION ZLOTYS VERSUS LOSS OF
22.9
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM73rdPZa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project